NorthWest Biotherapeutics Inc (NWBO)

[Ready4bluesky]

I'm still a little baffled with the question as to whether or not enrollment is complete. The idea that the temporary screening halt was just a normal expected step once enough patients were identified to exist in the pipeline doesn't seem to jive with a "temporary" change in screening or with the 8-k filed in October that includes a revised timeline to include "plus about a month of cushion to take account of the temporary hold on new screening for the trial as we announced in August." If this were normal progression to full enrollment, why would it result in additional time to trial completion?